What's new

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised

Apr 15, 2025 - 16:32
 0
Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, ...

Next Article

Why alcohol-free beer is thriving in Europe

Related Posts

Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 17/07/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025  0

Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0